For decades, the pharmaceutical industry hummed to the rhythm of small-molecule drugs - oral pills and injections that community and hospital pharmacies dispensed regularly. However, a seismic shift is underway with biologics, radionuclear agents, nanomedicines, and other novel therapeutics becoming more prevalent. At the heart of this transformation is gene therapy, poised to rewrite the score of care for many medical conditions. In some diseases gene therapy may be the answer to provide a complete cure, and pharmacists are at the front lines of this wave of change.

How do these agents work, and how are they delivered? Listen as we talk with Jill Blind, Pharmacy Manager of Investigational Drug Services at Nationwide Children’s Hospital in Columbus, Ohio. In this episode, we discuss the science behind gene therapy, her experiences with gene therapy and cellular therapy, and how pharmacists are intricately involved in developing and distributing these novel treatments.